| |
The leukemias are
a group of malignant disorders of the haemopoietic tissues
characteristically associated with increased number of
leucocytes in the blood. Or
Leukemias are a heterogeneous group of neoplasm arising from
malignant transformation of haemopoitic cells.
Leukemic cells proliferate primarily in the bone marrow and
lymphoid tissues where they interfere with normal haemopoesis
and immunity. Ultimately they emigrate in to the peripheral
blood and infiltrate other tissues. Thus leukemias are
progressive and fatal condition resulting in death most often
from hemorrhage or infections. The course may vary from a few
days or week to many years depending on the type.
EPIDEMIOLOGY
Leukemia account for 0.15 – 0.6% of the total medical
admission in many General hospitals in India. C.L.L. is less
common in India and neighboring countries when compared to
West.
Males are affected more frequently (both acute and chronic) than
females.
Male to female ratio-
Acute leukemia -- 3: 2
Chronic lymphocytic leukemia -- 2: 1
Chronic myeloid leukemia -- 1.3: 1
Frequency of leukemia seen in India:
C.M.L 25 – 30 %
A.M.L 20 - 25 %
A.L.L. 15 - 25 %
C.L.L. 1 – 2 %
Other varieties 1 -2 %
Age incidence:
Acute lymphoblastic leukemia is primarily a disease of children
and young adult, where as AML occurs primarily in adults. (ALL
shows a peak incidence in the 1- 5 age group.) Chronic
lymphocytic leukemia tends to occur in the elderly.
ETIOLOGY:
In majority of the patients the cause of the leukemia is
unknown.
There are certain factors associated with development of
leukaemia. They are as follows:
1. Ionising radiation: A significant increase in myeloid
leukemia
followed the atomic bombing of Japanese cities. An increase in
leukemia was observed after the use of radiotherapy for
ankylosing spondylitis and diagnostic X ray of the fetus in
pregnancy. Individual with occupational exposure, patients
receiving radiation therapy or Japanese survivors of the atomic
bomb explosion have a predictable and dose related increased
incidence of leukemia. Radiation exposure increases the risk of
developing CML, AML and possibly ALL, but there is no known
relationship to CLL or to hairy- cell leukemia.
2. Cytotoxic drugs: Cytotoxic drugs particularly alkylating
agent, may
Induce myeloid leukemia usually after a latent period of several
years. It had been noticed that in patients undergone alkylating
agent therapy for cancer of ovary, lung and breast had develop
acute leukemia after several months. Multiagent anti cancerous
chemotherapy may produce leukemia.
3. Exposure to benzene in industry: (chronic benzene exposure)
Exposure to other aromatic hydrocarbons may result in AML.
4. Retro viruses: One rare form of T cell leukemia lymphoma
appears to
be associated with a retrovirus- Human T Cell Leukemia Virus (HTLV)
5. Genetic and congenital disorders: There is increased
incidence of
leukemia in the identical twin of the patient with leukemia.
Increased incidence occurs in Down’s syndrome and other genetic
disorders like Bloom’s, Klinefelters, Fanconi’s and the Gonadal
dysgensis (xxy)
Wiskott- aldrich syndromes (due to defective nucleotide in the
platelet. Sex linked recessive. Bleeding from various sites.),
Ataxia telangiectasia and congenital agamma globulinemia are
also prone to terminate in acute leukemia.
6.Immunological: Immune deficiency states are associated with an
increase in haematological malignancy.
7.Predisposing hematologic diseases: Some haematological
diseases acquired during life have a remarkable tendency to
terminate as acute leukemia. Primary thrombocytopenia,
polycythemia vera, paroxysmal nocturnal hemoglobinuria and
hemopoietic stem cell disease may terminate in acute leukemia.
PATHOPHYSIOLOGY
Acute leukemia is characterised by proliferation of immature
myeloid or lymphoid cells. The leukemia arises following
malignant transformation of a single hemopoitic or lymphoid
progenitor followed by cellular replication and expansion of the
transformed clone. A fundamental characteristic of the malignant
cells in acute leukemia is their failure to mature beyond the
myeloblast or promyelocyte level in AML and the lymphoblast
level in ALL. Leukemic cells accumulate in bone marrow due to
excessive proliferation and to a defect in terminal
differentiation. The failure to mature to non-replicating end
cells is the primary reason for accumulation of leukemic cells
in AML. The leukemic cells proliferate primarily in the bone
marrow, circulating in the blood and may infiltrate in to other
tissue such as lymph node, liver, spleen, skin, viscera and the
central nervous system.
The leukemic blast
cells accumulate in the bone marrow and suppress the growth and
differentiation of normal haemopoitic cells. Thus AML &ALL
result in the diminished production of normal erythrocytes,
gametocyte & platelets. These deficiencies of normal cells leads
to the most important manifestation of this disease. Weakness,
fatigue and pallor as a result of anaemia. Infection as result
of granulocytopenia and hemorrhage as a result of
thrombocytopenia.
CLASSIFICATION
According to the cell type primarily involved leukemia are
classified into two. They are
1. Myeloid leukemia
2. Lymphoid lukaemia
According to the clinical behavior of the disease lukeamias are
classified into two.
1.Acute lukaemia
2. Chronic lukeamia.
Lukeamia Acute Chronic
1.Lymphoid 2.Myloid 1.Lymphoid 2.Myloid
(Lymphoblastic) (Myloblastic) (Lymphocytic) (Mylocytic)
SUB CLASSIFICATION
AML (F A B Classification)
M1 - Undifferentiated myeloblast
M2 - Differentiated myeloblast
M3 - Promyelocytic
M4 - Myelomonocytic
M5 - Monocytic
M6 - Erythrocytic
M7 - Megakaryocytic.
A L L
L1 - Blast cells are small and there is no appreciable
variation in size and shape. The nuclear chromatin is smooth and
the nucleoli are indistinct.
L2 -The blast cells vary in size with prominent nucleoli and a
variable amount of cytoplasm.
L3 - The cells are deeply basophilic with vacuolated cytoplasm.
C L L
1. Common B cell
2. Rare T cell
3. Hairy cell
4. Prolymphocytic
C M L
1. Philadelphia chromosome positive
2. Philadelphia negative, Break point cluster region positive
3. Philadelphia negative, Break point cluster region negative
4. Eosinophilic leukemia
SUBLEUKEMIC AND ALEUKEMIC LEUKEMIA
Not all leukemias are associated with an increased leucocyte
count or even the appearance of abnormal cells in the blood. The
sub leukemic is used when the leucocyte count is with in or
below normal limits but abnormal cells are seen in the blood.
Aleukemic is used when there are no abnormal cells to be seen
and leucocyte count is normal or subnormal.
Almost all patients who present with sub leukemic or aleukemic
disease have acute leukemias. The diagnosis is made from the
marrow.
ACUTE
UNDIFFERENTIATED LEUKEMIA (AUL)
In ALL the predominant cells are agranular blast cells.
Similarly granular blast cells are predominant in AML But in
rare cases of leukemia cells can not be classified by current
technique in to one of these two major categories and can be
referred to as AUL.
Note: Although leukemias are divided in to lymphoid and
myeloid varities recent advances have shown that this division
may be artificial since in acute leukemias both type may co
exist in the same patient.
ACUTE LEUKEMIAS
There is a failure of cell maturation in acute leukemias.
Proliferation of cells which do not mature leads to an
increasing accumulation of useless cells which take up more and
more marrow space at the expense of the normal haemopoitic
elements. Eventually this proliferation spills in to the blood.
CLINICAL FEATURES:
The patient usually present with non-specific flu- like
symptoms or vague malaise and tiredness. Bleeding manifestation
such as purpura, gum bleeding, mouth ulcers, herpes labialis and
sore throat etc are common to many disorders.
Symptoms of more diagnostic importance, which may reflect the
growth, or infiltration of leukaemic cells in the marrow include
persistent or recurrent skeletal pain or tenderness especially
the lower sternum and occasionally swelling of the large joint.
Hepatosplenomegaly in advanced stage Cervical lymphadinopathy
secondary to pharyngeal sepsis. But enlarged lymph node due to
the disease is a common feature of the lymphoblastic form.
Symptoms
Sign
Lab abnormalities
Cause
Fatigue/
Weakness
Pallor
Anaemia, hypocalcemia, Hyper calcemia & hypomagnesemia
Marrow failure, release of cellular ions and metabolits.
Weight loss
Weight loss
Reduced food intake, anaemia, increased catabolism
Bleeding from skin, mucus membrane, gums, gastrointestinal
tract, and genito urinary tract.
Purpura, gum oozing, or hypertrophy haematuria or melena.
Thrombocytopenia, hypofibrinogenemia, reduced factor 5 & 8 and
increased fibrin split products.
Marrow failure and disseminated intra vascular coagulation
Infection of skin, throat, gums, respiratory or urinary tract
Fever, chills and pyodermis gangrinosum
Granulocytopenia, X-ray evidence of infection like pneumonia
Sinusitis etc. positive cultures.
Marrow failure, granulocytopenia and immunodeficiency
Headache, nausea, vomiting, blurred vision and cranial nerve
dysfunction
Papilledema, cranial nerve palsy and meningeal irritation.
Spinal fluid pleocytosis, reduced CSF sugar and increased CSF
Protein
Meningeal, CNS or nerve infiltration and or compression.
Bone pain and tenderness
Increased bone tenderness
Abnormal bone marrow, X-ray (bone destruction)
Local leukemic infiltration
Abdominal fullness and anorexia
Hepatosplenomegaly, abdominal tenderness
Hyperfibrinigenemia, elevated SGOT, SGPT and alkaline Phosphates
Infiltration of abdominal viscera
Enlarged lymph node or tumour mass
Enlarged lymph node mass in node areas, skin, breast, testis.
Abnormal biopsy-liver, spleen, bone and gums.
Local tumor growth or infiltration
Oliguria
------------------
Constipation.
--------------------------
Concentrated urine, elevated BUN, and elevated uric acid
-------------------------
Dehydration, uric acid nephropathy, DIC
INVESTIGATION
Blood
Peripheral smear- blast cell
Anemia- normochromic type
MCV- either normal or raised.
Leukocyte count -may varies from as low as 1 X 109/l to as high
as 500 X 109/l or more.
The blood film appearance of blast cells and other primitive
cells are usually diagnostic.
In aleukemic form a bone marrow is necessary to establish the
diagnosis. Severe Thrombocytopenia is usual but not invariable.
Bone marrow
The bone marrow is the most valuable diagnostic investigation
The marrow is usually hypercellular with replacement of normal
elements by leukemia blast cells in varying degrees. The
presence of Auer rods in the cytoplasm of the blast cells
indicates a myeloblastic leukemia. Presence of blast cells in
excess of 30% of the total cells in the marrow confirms the
diagnosis of acute leukemia. Elevation above 5% should be noted
with suspicion.
OTHER
INVESTIGATIONS
Renal functions: Blood urea, creatinine.
Liver functions: Total protein, albumine, bilirubine, alkaline
phosphates, AST/ALT, gamma-GT
Hemostatic function: Coagulation screan, fibrinogen, and d-dimers.
Cellular proliferation: Plasma LDH, Plasma urate.
MANAGEMENT
Specific therapy: Bone marrow transplantation is a
therapeutic option for young patient who has histocompatibile
sibling donor. It is generally offered to the patient with AML
in first remission and those with ALL in first, second, or
subsequent remission.
Supportive therapy: Thrombocytopenic bleeding- requires platelet
transfusion.
Anemia: blood transfusion.
Infection: (unexplained fever >380c lasting over 6 hours in
neutropenic patient indicative the possible septicemia) Patients
with lymphoblastic leukemia are susceptible to infection with
pneumocystis carini, which causes severe pneumonia
Fungal infection: Oral or pharyngeal monilial infection is
common. Systemic fungal infection with candida or pulmonary
aspergillosis.
Viral infection: Herpes simplex infection occurs frequently
around the lips and nose.
Renal & Hepatic function should be monitored closely
particularly if the patient is receiving antibiotic, which is
also, nephrotoxic.
Protected environment
Psychological support
Isolation is often psychologically stressful for the patient.
Psychological support is important. An optimistic attitude from
the staff is vital. Delusion, hallucination and paranoia are not
uncommon during periods of severe bone marrow failure and
septicemic episodes and should be met with patience and
understanding.
Supportive observation:
Continuous monitoring of renal, hepatic, hemostatic function is
necessary together with fluid balance measurements. The patient
is often severely anorexic and may find drinking difficulty. The
necessary fluids and electrolytes often have to be given
intravenously as long as necessary.
HOMOEOPATHIC
MEDICINE
Ars alb, Nat ars, Nat sulph +++
Aurum met, Ars iod, Calc, Calc phos, Carb sulph, Fer picricum,
Nat mur, Nat phos, Picric acid, X-ray ++
Acetic acid, Aconite, Baryta iod, Baryta mur, Bry, Carbo veg,
Chin sulph, Conium, Crot c, Crot h, Merc sol, Nux vom, opium,
Phos, sulph, Thuja, Tuberculinum +
PROGNOSIS
Without treatment the survival of the patient with acute
leukemia is about five weeks. This may extend to about ten weeks
with supportive treatment. Patients who achieve remission with
specific therapy have a better out look (about 79 % of adult
patient with ALL and 60% with AML achieved remission. Survival
for ALL patients is about 30 months and for AML patient about 13
months if remission is achieved.)
BAD PROGNOSTIC
FACTORS IN ACUTE LEUKEMIA
1. Increasing age
2. Male sex
3. High leukocytes level at diagnosis.
4. Cytogenic abnormalities.
5. CNS involvement and diagnosis.
6. Thrombocytopenia below 1lakh.
7. Organomegaly.
8. T-cell ALL
9. Presence of mediastinal lymph node.
FAVORABLE PROGNOSTIC FACTORS
1. Initial leukocyte count below 20,000/cc
2. Platelet counts above 1 lakh.
3. Absence of organomegaly.
4. Absence of mediastinal lymphadenopahty.
5. Younger age group.
6. Absence of complications
Differences between acute and chronic leukemias
Acute Chronic
Age
More in the first & second decade but can occur in all age
group.
Mostly in the 4th, 5th and 6th decades. But even young children
may be affected rarely
Sex ratio
Male: female-2: 1
Male: female - 1: 1
Duration
Weeks to months
Several months to one year
Presenting complaints
Anaemia, fever infections,
haemorrhagic tendencies or complications especially
neurological.
Vague symptoms, loss of weight, mass in the abdomen or lymph -
nodular masses
Organomegaly
Liver, spleen and lymph node are moderately enlarged in 70 - 80%
of cases.
Moderate - gross spleenomegaly is the rule in CML. Moderate to
gross lymphadenopathy in cases.
Blood picture
Total leucocyte count is moderately elevated. 15-30000/cmm.
Blast cell from 10-90 % of the total. Platelets are often
reduced
Total leucocyte count is grossly elevated. 150 –250000/cmm
Bone marrow
Shows depression of erithroiedcells, myeloid cells and
megakaryocytes and infiltration by the abnormal cells. Blast
cells from more than 30 %and may be even up to 90%
CML increase in myeloid cells, especially myelocytes,
metamyelocytes and neutrophills. Infiltration by small
lymphocytes is seen in CLL. Erythriod and megakaryocytic
precursors may not be grossly suppressed in early stages.
Chromosomal studies
Variable
Philadelphia chromosome is demonstrable in 90 –95 % cases of CML
Course& prognosis
Untreated cases fatal within weeks to 6 months due to infection.
Haemorrhage, anaemia or other complications
Untreated CML has median survival of 18 –24 months. CLL has a
generally more prolonged course.
Response totreatment
Spontaneous remission have rarely been reported. With treatment
over 90 % of cases go in to remission and 60 – 70 % get complete
cure.
With chemotherapy practically no case is cured. But the course
is made more smooth and prolonged. With bone marrow
transplantation at the ideal time cure rate exceed 50 %
LEUKEMOID REACTION:
Leukemoid reaction is a non-neoplastic reactive leucocytosis
characterised by the presence of immature cells of all stages in
peripheral blood.
This may involve the myeloid, lymphatic or other cells types.
Childrens are affected more frequently than adults.
CAUSES: 1. Acute infections
E.g.: - pneumonia, whooping cough, chicken pox,
Diphtheria, meningitis etc.
2.Chronic infections
E.g.: - tuberculosis, amoebic liver abscess.
3. Haemolytic crisis and massive haemorrhages
4. Metastatic carcinoma involving bone marrow (especially from
neurofibroma, lungs etc.)
5.other haematological malignancies like multiple myeloma and
Hodgkin’s disease.
6.Toxic states like eclampsia, burns and mercury poisoning
Blood picture myeloid in - pneumonia, TB, amoebic liver abscess,
meningitis
metastatic carcinoma, multiple myeloma, post haemorrhage and
hemolysis.
Blood picture lymphoid in- whooping cough and chicken pox.
The bone marrow is normal with accelerated leucopoisis. No
hepatospleenomegaly. |
|